Vosoritide therapy in children with achondroplasia aged 3β59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial
Source: The Lancet Child & Adolescent Health Authors: Prof Ravi Savarirayan, MD β’ Prof William R Wilcox, MD β’ Prof Paul Harmatz, MD β’ John Phillips III, MD β’ Lynda…
